Bayer | Ophthalmology

Our partnership with ESASO exemplifies innovation in ophthalmology through focusing on advancing research and optimizing clinical studies in retinal diseases.   This collaboration is a testament to the power of shared expertise and a commitment to improving outcomes for patients with retinal conditions.   #OphthalmologyInnovation #PartnershipsInResearch #FutureOfVision

2024 has been a fantastic year for the Barometer Program! We wish you Happy New Year, and thank you for following the Program’s activities this past year! Follow our page, and visit the nAMD Barometer (https://lnkd.in/eNE3pUF5 DR Barometer (https://lnkd.in/eG39XcCq) websites to stay up to date with all the latest news and resources – we have lots planned for 2025! Learn about our continuing commitment to improve the vision health of people around the world through understanding barriers to treatment and by developing practical and meaningful interventions to help optimize clinical practice and improve patient outcomes. We look forward to continuing our support for the retinal community, patients, and their families in 2025, stay tuned!   International Agency for the Prevention of Blindness (IAPB)   International Federation on Ageing Vision Academy   #BarometerInitiative #Education #Awareness #nAMD #Collaboration 

Did you join us at the 12th International Congress of FLORetina Meeting? This milestone event brought together global experts to share the latest advancements in retina care and innovation.   At Bayer, we are committed to fostering collaboration within the ophthalmology community to advance solutions that improve patient outcomes and prevent vision loss. Share your favorite part of FLORetina in the comments below.   #FLORetina2024 #FLORetina

Please join us in congratulating Barometer Ambassador Committee member, PD Dr. Tina Herold, who drew an impressive crowd at the 122nd congress of the German Ophthalmological Society (DOG) in Berlin in October, presenting a poster titled “Patients’ and doctors’ perspectives on the challenges and opportunities of nAMD care: German results of the nAMD Barometer survey”.   PD Dr. Tina Herold and her co-authors Prof. Robert Finger, Prof. Albrecht Lommatzsch and Prof. Focke Ziemssen identified uncertainties in patients’ understanding of long-term treatment strategies as a barrier to adherence for patients in Germany with retinal disease. To ensure that patients in your clinic have access to consistent, accurate, and timely information, download our information brochures for patients with nAMD at time of diagnosis (https://lnkd.in/eBwAtjjs), treatment initiation (https://lnkd.in/eFFHk7wr) , and after 3 months of treatment (https://lnkd.in/eX8qVQfa). #PowerOfCollaboration #namd

This December, as we celebrate the United States #SafeToysandCelebrationsMonth, let's prioritize eye safety. At Bayer Ophthalmology, we recognize the joy that toys and games bring during the holiday season. But we also know the importance of ensuring they’re safe for play. Also, watch out for those popping champagne corks, keep adults and children safe alike and don’t let eye safety slide over the holiday time.1 Check out below some essential safety tips.

Hear from Professor Richard Gale, Consultant Medical Ophthalmologist, as he discusses how the burden of intravitreal therapies is among the highest unmet need of patients living with retinal diseases.   At Bayer we are committed to addressing high unmet medical needs to significantly reduce disease and treatment burden and help patients see a better life.   #Ophthalmology #UnmetNeed

#InternationalSharpsInjuryPreventionAwarenessMonth is focused on prevention of medical sharps injuries in the healthcare setting, yet safety for home carers and patients is also paramount. So, let’s focus on protecting you and your loved ones. Each year many people are seriously injured from contact with discarded needles in household waste.1 If you’re managing your health at home or you are a carer for someone who is and you need to use medical sharps like needles or lancets, safety truly matters. It goes without saying, but always keep medical sharps away from your eyes. Please see some tips below but do follow the instructions given by your healthcare provider and reach out to them with any questions. Always be sharps smart and stay in the know. #SharpsSafety #EyeCare #PatientSafety

Identifying patients who will derive long-term benefit from anti-VEGF treatment is a difficult, but very important, treatment decision. Share with us in the comments the steps you take in your clinic to investigate if treatment cessation is best for your patient.    Listen to the new episode of “A Chat with Anat” on Spotify (https://bit.ly/3ZhLrLL) or Apple (https://bit.ly/4f1s9Aa), where Professor Anat Loewenstein is joined by fellow Vision Academy and Barometer member Professor David Wong to discuss treatment futility and treatment success in the context of suspending anti-VEGF treatment of nAMD. Click to download the Vision Academy flowchart (https://bit.ly/48Yhwwy) discussed in the podcast, in the Viewpoint and slide deck (https://bit.ly/3AUj3Hv).    Explore more episodes of “A Chat with Anat” on Spotify or Apple, to hear Anat discuss other key topics with internationally renowned experts on how to enhance care and optimize treatment for patients with retinal disease.    #ExpandKnowledge #Awareness #VisionAcademy

Watch as Dr Varun Chaudhary, Vitreoretinal surgeon and chief of ophthalmology, McMaster University, Canada shares the benefits of longer treatment intervals for patients and caregivers. #Ophthalmology #Patient 

There are many ways in which retinal specialists can empower patients to prioritize their health needs, and we’d love to hear yours. Comment below how you motivate the patients in your clinic to be adherent.     To learn about the strategies that Professor Anat Loewenstein and Professor Richard Gale, Consultant Medical Ophthalmologist and the Clinical Director at York Teaching Hospital NHS Foundation Trust, employ in their busy clinics, listen to this episode of “A Chat with Anat” on Spotify (https://bit.ly/3tZdRyo) or Apple (https://apple.co/3On1TFq).    Explore more episodes of “A Chat with Anat” on Spotify or Apple, to hear Anat discuss other key topics with internationally renowned experts on how to enhance care and optimize treatment for patients with retinal disease.    #ExpandKnowledge #Awareness